PBS Biotech

PBS Biotech designs scalable, single-use bioreactors ranging from 0.1L to 80L, enabling scientists to advance cell therapy treatments for cancer, diabetes, and heart failure. Unlock the full potential of your cell therapy with PBS Biotech's innovative products and services. Our products and services support the scalable manufacturing of allogeneic therapies derived from cells like induced pluripotent stem cells, mesenchymal stem cells, and CAR-T or NK cells. Whether you're in the early stages or preparing for clinical trials and commercialization, we help accelerate your therapeutic product's journey.